
Predawn Versus Preiftar Timing of Levothyroxine Administration During Ramadan Intermittent Fasting: A Multicenter Randomized Controlled Trial
EndocrinologiaResumo original em inglês
O que aconteceu
To compare 2 levothyroxine (LT4) dosing regimens during Ramadan: preiftar and predawn, with respect to thyroid biochemical control and patient satisfaction.
This multicenter, open-label randomized controlled trial recruited adults with primary hypothyroidism from 3 Saudi cities (Jeddah, Riyadh, and Al-Ahsa). Patients with thyroid cancer were excluded. Thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels were measured 2 weeks before and 4 to 6 weeks after Ramadan. Participants were randomized to take LT4 either before breaking the fast (preiftar) or just before fasting began (predawn).
O que encontraram
A total of 303 (156 preiftar and 147 predawn) participants completed the study. Groups were comparable in demographic characteristics and comorbidities. Mean age was 49 ± 12 years; 87% were female; mean disease duration was 9.7 ± 8.3 years. Weekly LT4 dose was 753 ± 349 μg (preiftar) versus 733 ± 266 μg (predawn; P = .001). Pre-Ramadan TSH level was 2.56 ± 2.16 mIU/L versus 2.46 ± 1.72 mIU/L (P = .3), and FT4 level was 13.45 ± 2.1 versus 13.08 ± 2.4 pmol/L (P = .16). Post-Ramadan TSH level was 3.64 ± 4.1 versus 4.07 ± 4.2 mIU/L (P = .78), and FT4 level was 12.96 ± 0.1 versus 12.64 ± 0.2 pmol/L (P = .003). Within-group post-Ramadan changes were nonsignificant. Repeated measures analysis of variance showed no significant differences in TSH or FT4 levels over time or between groups (P = .47 and P = .81). Compliance and satisfaction were comparable.
Por que isso importa
Both preiftar and predawn LT4 regimens maintained thyroid stability during Ramadan. Either can be safely adopted according to patient preference.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Predawn Versus Preiftar Timing of Levothyroxine Administration During Ramadan Intermittent Fasting: A Multicenter Randomized Controlled Trial
Reem M Alamoudi, Samah Nawar, Abdulrhman Al Mulla, Hiba Alharbi, Ali Alqarni, Abdullah M Alzahrani, Walaa Busaad, Nasser Alahmari, Nouf Alshamrani, Lujain Alkhalifa et al.
Descritores MeSH
- Intermittent Fasting
- Fasting
- Hypothyroidism
- Islam
- Thyroxine
- Humans
- Thyrotropin
- Patient Satisfaction
- Male
- Middle Aged